Medifast, Inc.
MED
$10.53
$0.100.96%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 75.10M | 89.41M | 105.56M | 115.73M | 119.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 75.10M | 89.41M | 105.56M | 115.73M | 119.00M |
| Cost of Revenue | 22.96M | 27.25M | 28.91M | 31.48M | 30.78M |
| Gross Profit | 52.14M | 62.16M | 76.64M | 84.25M | 88.22M |
| SG&A Expenses | 58.94M | 65.14M | 76.61M | 84.51M | 73.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 82.90M | 93.49M | 106.62M | 116.99M | 105.79M |
| Operating Income | -7.80M | -4.08M | -1.07M | -1.26M | 13.21M |
| Income Before Tax | -6.38M | -2.66M | 2.88M | 526.00K | 1.28M |
| Income Tax Expenses | 11.74M | -396.00K | 395.00K | 1.30M | 474.00K |
| Earnings from Continuing Operations | -18.12M | -2.26M | 2.48M | -772.00K | 801.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.12M | -2.26M | 2.48M | -772.00K | 801.00K |
| EBIT | -7.80M | -4.08M | -1.07M | -1.26M | 13.21M |
| EBITDA | -4.34M | -629.00K | 2.98M | 2.02M | 16.40M |
| EPS Basic | -1.65 | -0.21 | 0.23 | -0.07 | 0.07 |
| Normalized Basic EPS | -0.36 | -0.15 | 0.16 | 0.03 | 0.79 |
| EPS Diluted | -1.65 | -0.21 | 0.22 | -0.07 | 0.07 |
| Normalized Diluted EPS | -0.36 | -0.15 | 0.16 | 0.03 | 0.78 |
| Average Basic Shares Outstanding | 10.99M | 10.99M | 10.99M | 10.95M | 10.94M |
| Average Diluted Shares Outstanding | 10.99M | 10.99M | 11.06M | 10.95M | 10.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.00% | 0.00% | 0.04% | -25.13% | 0.00% |